Familial language network vulnerability in primary progressive aphasia.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
18 08 2020
Historique:
received: 09 12 2019
accepted: 27 02 2020
pubmed: 24 7 2020
medline: 21 10 2020
entrez: 24 7 2020
Statut: ppublish

Résumé

To investigate evidence of the potential role of early cortical vulnerability in the development of primary progressive aphasia (PPA). A woman with a diagnosis of PPA and her 9 adult siblings, 7 with developmental language disabilities, underwent neuropsychological testing, structural MRI, and resting-state fMRI. Whole-exome sequencing was conducted for genes associated with dyslexia or with neurodegenerative dementia. The siblings demonstrated lower verbal than nonverbal cognitive test scores in a developmental dyslexia pattern. On structural MRI, although the siblings did not differ from controls in total brain volume, the left hemisphere language area volume was significantly smaller than the right. Furthermore, cortical connectivity between the left superior temporal area, previously identified as the region of peak atrophy in the proband early in the course of illness, and adjacent language network components, including the planum temporale, was decreased in the siblings. No distinctive genetic signatures were identified. This report further supports the hypothesis that at least some cases of PPA may be based on a familial language network vulnerability that interferes with the acquisition of language in some members and that makes the language network a locus of least resistance to the effects of an independently late-arising neurodegenerative disease in others. This association offers a conceptual model to explain why identical neurodegenerative diseases may selectively target the language network in some individuals while targeting networks that regulate memory or behavior in others. The genetic basis for this vulnerability remains to be determined.

Identifiants

pubmed: 32699140
pii: WNL.0000000000009842
doi: 10.1212/WNL.0000000000009842
pmc: PMC7605508
doi:

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e847-e855

Subventions

Organisme : NIDCD NIH HHS
ID : R01 DC008552
Pays : United States
Organisme : NIDCD NIH HHS
ID : K23 DC014303
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS075075
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG013854
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG056258
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 American Academy of Neurology.

Références

Alzheimers Dement. 2019 Apr;15(4):543-552
pubmed: 30765195
Can J Neurol Sci. 1997 Feb;24(1):29-36
pubmed: 9043744
J Clin Exp Neuropsychol. 2004 May;26(3):347-55
pubmed: 15512925
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Brain. 2013 Nov;136(Pt 11):3461-73
pubmed: 24056533
Brain. 2014 Apr;137(Pt 4):1176-92
pubmed: 24574501
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Alzheimers Dement. 2011 May;7(3):293-9
pubmed: 21575870
Nat Rev Neurol. 2014 Oct;10(10):554-69
pubmed: 25179257
J Neurophysiol. 2010 Jan;103(1):297-321
pubmed: 19889849
J Neurosci. 2006 Oct 18;26(42):10700-8
pubmed: 17050709
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Int Neuropsychol Soc. 2013 Mar;19(3):272-83
pubmed: 23298442
Science. 2001 Mar 16;291(5511):2165-7
pubmed: 11251124
Ann Neurol. 2001 Apr;49(4):425-32
pubmed: 11310619
JAMA Neurol. 2014 Dec;71(12):1576-7
pubmed: 25486208
Neuron. 2011 Oct 20;72(2):245-56
pubmed: 21944778
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
Neuropsychologia. 1994 Oct;32(10):1225-31
pubmed: 7845562
IEEE Trans Med Imaging. 2007 Apr;26(4):518-29
pubmed: 17427739
Baillieres Clin Neurol. 1992 Nov;1(3):583-609
pubmed: 1344204
Alzheimer Dis Assoc Disord. 2004 Oct-Dec;18(4):223-30
pubmed: 15592135
Neurology. 1981 May;31(5):625-8
pubmed: 7194980
Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):10-17
pubmed: 29240561
Arch Neurol. 2004 Feb;61(2):265-8
pubmed: 14967776
Neurology. 2014 Sep 23;83(13):1184-91
pubmed: 25165386
Neurology. 2015 Aug 18;85(7):652-3
pubmed: 26203093
Am J Alzheimers Dis Other Demen. 2009 Oct-Nov;24(5):408-16
pubmed: 19700669
Arch Neurol. 2009 Dec;66(12):1545-51
pubmed: 20008661
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):18035-40
pubmed: 19004769
Int Psychogeriatr. 1997;9 Suppl 1:173-6; discussion 177-8
pubmed: 9447441
Arch Neurol. 2008 Feb;65(2):244-8
pubmed: 18268195
Neuroimage. 2004 Oct;23(2):724-38
pubmed: 15488422
Pediatr Rev. 2003 May;24(5):147-53
pubmed: 12728187
Neuroimage. 2012 Feb 1;59(3):2142-54
pubmed: 22019881

Auteurs

Sandra Weintraub (S)

From the Mesulam Cognitive Neurology and Alzheimer's Disease Center (S.W., B.M.R., C.C., J.S., J.W., B.B., E.J.R., M.M.M.), Department of Psychiatry and Behavioral Sciences (S.W., E.J.R.), and Department of Neurology (B.B., M.M.M.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Epidemiology (B.M.R.), Boston University School of Public Health, MA; Northwestern University Weinberg School of Arts and Sciences (K.A.G.), Evanston, IL; and Department of Psychiatry (G.C., E.M.R.), Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles. sweintraub@northwestern.edu.

Benjamin Rader (B)

From the Mesulam Cognitive Neurology and Alzheimer's Disease Center (S.W., B.M.R., C.C., J.S., J.W., B.B., E.J.R., M.M.M.), Department of Psychiatry and Behavioral Sciences (S.W., E.J.R.), and Department of Neurology (B.B., M.M.M.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Epidemiology (B.M.R.), Boston University School of Public Health, MA; Northwestern University Weinberg School of Arts and Sciences (K.A.G.), Evanston, IL; and Department of Psychiatry (G.C., E.M.R.), Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.

Christina Coventry (C)

From the Mesulam Cognitive Neurology and Alzheimer's Disease Center (S.W., B.M.R., C.C., J.S., J.W., B.B., E.J.R., M.M.M.), Department of Psychiatry and Behavioral Sciences (S.W., E.J.R.), and Department of Neurology (B.B., M.M.M.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Epidemiology (B.M.R.), Boston University School of Public Health, MA; Northwestern University Weinberg School of Arts and Sciences (K.A.G.), Evanston, IL; and Department of Psychiatry (G.C., E.M.R.), Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.

Jaiashre Sridhar (J)

From the Mesulam Cognitive Neurology and Alzheimer's Disease Center (S.W., B.M.R., C.C., J.S., J.W., B.B., E.J.R., M.M.M.), Department of Psychiatry and Behavioral Sciences (S.W., E.J.R.), and Department of Neurology (B.B., M.M.M.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Epidemiology (B.M.R.), Boston University School of Public Health, MA; Northwestern University Weinberg School of Arts and Sciences (K.A.G.), Evanston, IL; and Department of Psychiatry (G.C., E.M.R.), Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.

Jessica Wood (J)

From the Mesulam Cognitive Neurology and Alzheimer's Disease Center (S.W., B.M.R., C.C., J.S., J.W., B.B., E.J.R., M.M.M.), Department of Psychiatry and Behavioral Sciences (S.W., E.J.R.), and Department of Neurology (B.B., M.M.M.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Epidemiology (B.M.R.), Boston University School of Public Health, MA; Northwestern University Weinberg School of Arts and Sciences (K.A.G.), Evanston, IL; and Department of Psychiatry (G.C., E.M.R.), Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.

Kyla A Guillaume (KA)

From the Mesulam Cognitive Neurology and Alzheimer's Disease Center (S.W., B.M.R., C.C., J.S., J.W., B.B., E.J.R., M.M.M.), Department of Psychiatry and Behavioral Sciences (S.W., E.J.R.), and Department of Neurology (B.B., M.M.M.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Epidemiology (B.M.R.), Boston University School of Public Health, MA; Northwestern University Weinberg School of Arts and Sciences (K.A.G.), Evanston, IL; and Department of Psychiatry (G.C., E.M.R.), Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.

Giovanni Coppola (G)

From the Mesulam Cognitive Neurology and Alzheimer's Disease Center (S.W., B.M.R., C.C., J.S., J.W., B.B., E.J.R., M.M.M.), Department of Psychiatry and Behavioral Sciences (S.W., E.J.R.), and Department of Neurology (B.B., M.M.M.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Epidemiology (B.M.R.), Boston University School of Public Health, MA; Northwestern University Weinberg School of Arts and Sciences (K.A.G.), Evanston, IL; and Department of Psychiatry (G.C., E.M.R.), Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.

Eliana Marisa Ramos (EM)

From the Mesulam Cognitive Neurology and Alzheimer's Disease Center (S.W., B.M.R., C.C., J.S., J.W., B.B., E.J.R., M.M.M.), Department of Psychiatry and Behavioral Sciences (S.W., E.J.R.), and Department of Neurology (B.B., M.M.M.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Epidemiology (B.M.R.), Boston University School of Public Health, MA; Northwestern University Weinberg School of Arts and Sciences (K.A.G.), Evanston, IL; and Department of Psychiatry (G.C., E.M.R.), Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.

Borna Bonakdarpour (B)

From the Mesulam Cognitive Neurology and Alzheimer's Disease Center (S.W., B.M.R., C.C., J.S., J.W., B.B., E.J.R., M.M.M.), Department of Psychiatry and Behavioral Sciences (S.W., E.J.R.), and Department of Neurology (B.B., M.M.M.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Epidemiology (B.M.R.), Boston University School of Public Health, MA; Northwestern University Weinberg School of Arts and Sciences (K.A.G.), Evanston, IL; and Department of Psychiatry (G.C., E.M.R.), Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.

Emily J Rogalski (EJ)

From the Mesulam Cognitive Neurology and Alzheimer's Disease Center (S.W., B.M.R., C.C., J.S., J.W., B.B., E.J.R., M.M.M.), Department of Psychiatry and Behavioral Sciences (S.W., E.J.R.), and Department of Neurology (B.B., M.M.M.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Epidemiology (B.M.R.), Boston University School of Public Health, MA; Northwestern University Weinberg School of Arts and Sciences (K.A.G.), Evanston, IL; and Department of Psychiatry (G.C., E.M.R.), Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.

M Marsel Mesulam (MM)

From the Mesulam Cognitive Neurology and Alzheimer's Disease Center (S.W., B.M.R., C.C., J.S., J.W., B.B., E.J.R., M.M.M.), Department of Psychiatry and Behavioral Sciences (S.W., E.J.R.), and Department of Neurology (B.B., M.M.M.), Northwestern Feinberg School of Medicine, Chicago, IL; Department of Epidemiology (B.M.R.), Boston University School of Public Health, MA; Northwestern University Weinberg School of Arts and Sciences (K.A.G.), Evanston, IL; and Department of Psychiatry (G.C., E.M.R.), Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH